Recent Updates
Recently added Catalysts
TRI LOCUM PARTNERS LP
Track TRI LOCUM PARTNERS LP's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Sep 18, 2026
Showing 6 Stocks Out Of 19. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 DFTX | DEFINIUM THERAPEUTICS INC | 163.00 K | 7.67 M | 0.9 | |
 BBNX | BETA BIONICS INC | 493.34 K | 7.73 M | 1 | |
 DXCM | DEXCOM INC | 820.48 K | 55.26 M | 6.8 | |
 RVMD | REVOLUTION MEDICINES INC | 151.82 K | 28.43 M | 3.5 | |
 ELVN | ENLIVEN THERAPEUTICS INC | 866.72 K | 43.98 M | 5.4 | |
 DNTH | DIANTHUS THERAPEUTICS INC | 120.71 K | 11.77 M | 1.4 |
Market Value
$ 813.22 M
Holdings
19
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
14.13 %